Muhammad A Rahman retweeted
Thanks to your support, we've been able to buy 15 new life-saving miniature heart pump devices. 💙
Find out more in our latest Impact Report for 2024-2025: sheffieldhospitalscharity.or…
Muhammad A Rahman retweeted
Sheffield Hospitals Charity fund world's smallest heart pump technology to save lives trib.al/UyyVD7F
Muhammad A Rahman retweeted
ICYMI: Registration is now open for...
Prevention and Management of TAVI Complications
🗓️ Thursday 23 – Friday 24 October 2025
📍Mercure Sheffield St Paul's Hotel
Join the 3rd edition of Prevention and Management of TAVI Complications. A must-attend, highly interactive event bringing together TAVI implanters from across the UK.
💡 Learn from real-world cases.
🛠️ Explore how to prevent and manage complications.
🏆 Showcase your expertise—fellow-led case session with a prize for best presentation!
Exclusively for TAVI implanters including consultants and TAVI fellows.
Register here: millbrook-events.co.uk/TAVIC…
Muhammad A Rahman retweeted
Congratulations to Prof Alexander Rothman who has received the Michael Davies Early Career Award at #BCS2025.
We’re so proud to have been part of your research journey as you continue develop more accessible and empowering ways to treat people with Pulmonary Hypertension.
Muhammad A Rahman retweeted
Packed house for the BCS Young Investigators session - fantastic presentations !
Great opportunity for interventional trainees/fellows to join us as a TAVI fellow. #sheffieldhospitals @TAVRBot jobs.nhs.uk/candidate/jobadv…
Muhammad A Rahman retweeted
Such a challenging #TAVRinTAVR livecase at #RSH2025 from Sheffileld!
#Chimney @javaidiqbal_uk
@O_Azizy_MD @MBalghith @AndreasRck2 @Hragy @mmamas1973 @chiragbavishiMD @IhabFathiSulima @RHAAttar @Almanfi_Cardio @assiri99 @DFahadAlmehmadi @DrAlshatti @purviparwani @HeartStructural
Muhammad A Rahman retweeted
Stunning live complex valve-in-valve procedure utilizing chimney stenting to prevent significant obstruction of the dominant low RCA
@HeartStructural
#RSH2025
Muhammad A Rahman retweeted
EARLY TAVR published. Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes, driven by the latter. The study's findings may be limited by factors such as its unavoidable unblinded nature, trial-specific vigilance levels, low-risk patient selection, and use of a single valve type. #TCT2024
nejm.org/doi/full/10.1056/NE…
Muhammad A Rahman retweeted
EARLY TAVR trial shows in asymptomatic severe AS, early TAVR results in reduction of death/stroke/unplanned CV hospitalization, no difference in mortality or stroke #TCT2024
Great to share our experience and learn from TAVI colleagues at the second TAVI complications meeting at Sheffield. #tavr #CardioTwitter
Muhammad A Rahman retweeted
We have a complex coronary interventional fellow post at Glenfield Hospital available in the new year. The post offers exposure to all aspects of complex and CTO PCI. Feel free to contact me if you are interested and would like to discuss. Link below 👇
jobs.nhs.uk/candidate/jobadv…
Muhammad A Rahman retweeted
Resource Utilization and Costs Associated With Cardiogenic Shock Complicating Myocardial Infarction: A Population-Based Cohort Study
AMI-CS is associated with significant health care costs, both during the index hospitalization and following discharge
jacc.org/doi/10.1016/j.jacad…
Great to add Hydra valve to our armamentarium in dealing with severe AS. Excellent haemodynamic results in a high risk patient @oledebecker @amirazizcardio Kenny morgan, Javaid iqbal @melnev72 #CardioTwitter @CardioLegend #TAVRBot
Muhammad A Rahman retweeted
1/
DanGer Shock Trial
“Impella might finally get to brag about a positive trial”!
nejm.org/doi/full/10.1056/NE…
Muhammad A Rahman retweeted
LBCT #SMART trial @ACCinTouch #ACC24 #Evolut small annulus ⬇️MG SVD PPM PVL ⬆️KCCQ vs S3. Congrats @ @NEJM @HowieHerrmannMD @Drroxmehran @didier_tchetche
nejm.org/doi/full/10.1056/NE…
Muhammad A Rahman retweeted
#DanGer_Shock trial @NEJM is published: microaxial flow pump (#Impella) in #STEMI_cardiogenic_shock:
1. Lower risk of all-cause death 180/7: NNT 8
2. Higher incidence of a composite of adverse events: NNT 6
doi.org/10.1056/NEJMoa231257…
@mmamas1973 @AndrewJSauer #CardioTwitter
Muhammad A Rahman retweeted
nhsjobs.com/job/UK/Essex/Bas…
We have 2 fully funded interventional MD fellow posts up for grabs starting 2024. Coro physiology / CHIP. Please DM for a chat. @rallamee @MedCrisis @CCook_MD @grkaramasis @NickCurzen @divaka_perera @Ryvetsprog @DrPaulRees @DrNileshPareek @Dizzledavies73
Muhammad A Rahman retweeted
Interesting new evidence summary for OHCA management from the AHA, specifically looking at post-ROSC interventions.
How many UK centres have the facilities to offer this sort of state-of-the-art management? #postcodelottery
📖 ahajournals.org/doi/10.1161/… – at Manchester, England










































